Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Executive dysfunction in major depressive disorder.

Charles DeBattista1

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA. debattista@stanford.edu

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary

Executive dysfunction, including issues with planning and task completion, is common in major depression. This can lead to disability and impact treatment, though some therapies show promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

The American journal of psychiatry·2026
Same author

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
Same author

Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
Same author

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Journal of affective disorders·2025
Same author

Correction: Treatment of Refractory Bipolar Depression With Stereotactic Radiosurgery Targeting the Subgenual Cingulate Cortex.

Cureus·2025
Same author

Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of Life.

The Journal of clinical psychiatry·2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Executive dysfunction is a frequent symptom in major depression.
  • Deficits include problems with planning, initiation, and completion of goal-directed activities.
  • Executive dysfunction severity may correlate with depression severity, particularly in geriatric depression.

Purpose of the Study:

  • To review the impact of executive dysfunction in major depression.
  • To explore associations with vocational disability and treatment response.
  • To summarize current understanding of treatment interventions for executive dysfunction in depression.

Main Methods:

  • Literature review of studies on executive function in depression.
  • Analysis of the relationship between executive dysfunction, depression severity, and outcomes.

Related Experiment Videos

  • Synthesis of findings on pharmacologic and psychosocial interventions.

    • Main Results:

    • Executive dysfunction is linked to vocational disability and potentially poorer treatment outcomes in depression.
    • Geriatric depression may present with particularly pronounced executive deficits.
    • Preliminary evidence suggests pharmacologic and problem-solving therapies may be effective.

    Conclusions:

    • Executive dysfunction is a significant clinical feature of major depression with practical consequences.
    • Targeting executive deficits may improve outcomes for individuals with depression.
    • Further research into effective treatments for executive dysfunction in depression is warranted.